Relax (MIORELAXANT)

Quick links

Choose a section

Quick links to important sections

Advertisements

Relax (MIORELAXANT)

Advertisements
Advertisements

Method of action: Miorelaxant

Treatment option:

Advertisements

Overview of Relax (MIORELAXANT)

Relax (MIORELAXANT) is a synthetic, fixed-dose combination product designed to provide symptomatic relief from acute musculoskeletal discomfort. It is classified as both a Centrally Acting Skeletal Muscle Relaxant and a Non-opioid Analgesic, leveraging a dual mechanism of action to target both muscle tension and pain.

Property Description
Active ingredient Acetaminophen (Paracetamol) and Chlorzoxazone
Form Oral Tablet
Pharmacological class Centrally Acting Skeletal Muscle Relaxant, Non-opioid Analgesic
Common use Relief of acute muscle spasm and associated pain
Origin Synthetic

What Type of Medicine is Relax (MIORELAXANT)?

Relax (MIORELAXANT) is an oral tablet that combines two separate pharmacological compounds. Its classification as a Centrally Acting Skeletal Muscle Relaxant is due to Chlorzoxazone, a compound that acts in the central nervous system to reduce the heightened nerve reflexes responsible for involuntary skeletal muscle spasm. The inclusion of Acetaminophen defines its secondary class as a Non-opioid Analgesic/Antipyretic. The combination is used as an adjunct therapy, meaning it is intended to supplement fundamental care like rest and physical therapy, focusing on managing the immediate symptoms of acute injury or strain. This specific combination formulation is clinically recognized for its utility in managing acute, painful muscle conditions where both spasm and pain are significant factors.


The Composition: Acetaminophen and Chlorzoxazone

The medication's effectiveness is rooted in its two active ingredients: Chlorzoxazone and Acetaminophen (Paracetamol). Chlorzoxazone primarily functions by inhibiting multisynaptic reflex arcs at the spinal cord level, which reduces muscle hypertonicity. Acetaminophen contributes to the relief by modifying how the body processes pain signals in the central nervous system. The fixed-dose combination structure of Relax (MIORELAXANT) is a distinctive feature of this formulation compared to single-ingredient muscle relaxants.

Chlorzoxazone acts on the spinal cord and subcortical areas of the brain, leading to a reduction of muscle spasm and resulting in relief of pain and increased mobility. The fundamental goal of the combination is to simultaneously relax the spastic muscle and mitigate the patient's discomfort. The fixed-dose combination provides a singular way to address the interconnected symptoms of acute muscle conditions, such as discomfort following a sudden back strain.

Regulatory References

  1. Acetaminophen - StatPearls - NCBI Bookshelf - NIH
Advertisements

What side effects are possible with Relax (MIORELAXANT)?

The safety profile for Relax (MIORELAXANT), a combination of Chlorzoxazone and Acetaminophen, is formally structured around common central nervous system effects and rare but serious systemic risks, as detailed in governmental regulatory documents.


Officially Documented Adverse Reactions

Adverse effects are categorized by frequency and the organ system affected:

  • Common/Occasional Reactions (Nervous System): The most frequently noted adverse effects are related to the central depressant action of Chlorzoxazone. These include drowsiness, dizziness, light-headedness, and a general feeling of malaise. Gastrointestinal effects like nausea and vomiting may also be noted, often at the initiation of treatment.

  • Rare but Serious Reactions (Hepatic & Dermatological): The combination carries an explicit risk of severe liver damage (hepatocellular toxicity). This includes rare, unpredictable, and potentially fatal idiosyncratic reactions linked to Chlorzoxazone, and dose-dependent toxicity from Acetaminophen, especially if the maximum daily limit is exceeded. Severe skin reactions, such as Stevens-Johnson syndrome, and anaphylactic reactions are also classified as rare risks.


Safety Constraints and Special Populations

Official labeling includes specific constraints regarding use and concurrent conditions:

  • Severe Hepatic Impairment: The medication is contraindicated in individuals with severe hepatic impairment or active liver disease due to the metabolic burden of both active components.

  • Co-Ingestion: The use of alcohol or other Central Nervous System (CNS) depressants alongside this medication may result in an additive depressant effect. Safety restrictions also prohibit taking the medicine with other products containing Acetaminophen.

  • Monitoring Note: Patients experiencing signs of liver dysfunction, such as jaundice, dark urine, or fever, should have the medication discontinued immediately. A harmless, transient orange or purplish-red discoloration of the urine may also occur due to a drug metabolite.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Relax (MIORELAXANT) involves the distinct toxicological risks associated with both active components. Immediate medical attention must be sought right away, as mandated by regulatory authorities, even if initial symptoms are not yet apparent or seem mild. This required action is critical due to the potential for severe, delayed toxicity.

Acute manifestations of overdose may include signs of central nervous system depression, such as drowsiness, malaise, and sluggishness, accompanied by a marked loss of muscle tone and decreased deep tendon reflexes. Severe outcomes related to the muscle relaxant component may involve respiratory depression and lowered blood pressure (hypotension).

The primary life-threatening risk stems from the Acetaminophen component, which can lead to acute liver failure (hepatotoxicity). Early symptoms of this toxicity can be delayed and may present as nausea, vomiting, sweating, and abdominal pain. Individuals with pre-existing liver disease or those who consume three or more alcoholic beverages daily are explicitly noted in regulatory documents as being at increased risk for severe damage.

Management is focused on symptomatic and supportive care. While no specific antidote exists for the muscle relaxant component, the administration of N-acetylcysteine (NAC) is the established treatment for Acetaminophen toxicity. Official procedures also require decontamination measures like activated charcoal and hospital monitoring of serum drug concentration and hepatic function to guide clinical management.

Advertisements

Therapeutic Uses of Relax (MIORELAXANT)

What Relax (MIORELAXANT) treats: main uses and benefits

The medication is commonly used to provide symptomatic relief in conditions presenting with acute episodes marked by sudden, involuntary muscle spasm and significant hypertonicity (tightness). The therapeutic intent is to assist with reducing involuntary skeletal muscle spasms. It is relevant for easing symptoms related to localized physical discomfort, such as neck strain, low back pain, and muscle sprains. The medication is relevant for easing symptoms associated with acute musculoskeletal discomfort.

The combination of a muscle relaxant and a non-opioid analgesic within the formulation is relevant for easing symptoms related to physical discomfort and pain intensity, especially when these symptoms create noticeable functional strain. The medication is generally applied during short-term, symptomatic phases as an adjunct therapy, supplementing fundamental care like rest or physical therapy.

“This supportive therapeutic approach helps address symptom clusters that may become intense or disruptive, especially when short-term symptomatic assistance is needed.”

It is considered relevant when acute manifestations interfere with function, providing supportive relief that helps ease the overall symptom burden and assists with maintaining functional stability during symptomatic periods.

Quick Fact: The medication is relevant for easing symptoms associated with acute musculoskeletal discomfort.

Regulatory References

  1. DailyMed, a service of the NIH
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Relax (MIORELAXANT)?

The eligibility for Relax (MIORELAXANT), a fixed-dose combination of Acetaminophen and Chlorzoxazone, is strictly defined by regulatory documents, focusing on patient age, pre-existing conditions, and physiological status.

Contraindications and Restrictions

Population/Condition Eligibility Status (Regulatory Wording)
Severe Active Liver Disease Contraindicated (Absolute prohibition)
Hypersensitivity Contraindicated (Known allergy to components)
Children under 12 years Use Not Established (Not recommended)
Pregnancy/Lactation Restricted / Not Recommended (Insufficient data)
Severe Renal Impairment Caution/Restricted (Conditional use)

The medicine is generally indicated for use in adults and adolescents (typically 16 years and older). Regulatory labeling imposes absolute contraindications for patients with severe hepatic impairment due to the Acetaminophen component, and for individuals with known hypersensitivity to either active ingredient. Use in the pediatric population is not established and therefore not recommended.

Furthermore, use in older adults requires caution due to increased susceptibility to central nervous system effects. Eligibility is also constrained by physiological states: use during both pregnancy and lactation is generally not recommended or restricted because adequate safety data are lacking in these groups.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This medication's interaction profile is based on the two active components: Chlorzoxazone and Acetaminophen. Officially documented information emphasizes the avoidance of additive toxicity and pharmacodynamic potentiation.

Contraindicated Combinations and Conditions

Co-administration with other acetaminophen-containing products is strictly prohibited to prevent exceeding the maximum daily dose and to mitigate the risk of severe liver injury and acute liver failure. The product is formally contraindicated for use in patients with severe hepatic impairment or active liver disease, a restriction tied to the heightened risk of toxicity from the Acetaminophen component.

Documented Pharmacodynamic and Exposure Interactions

Due to the Chlorzoxazone component, co-use with Central Nervous System (CNS) depressants (including opioids, sedatives, and anxiolytics) results in additive CNS depression, increasing the risk of profound sedation. Concomitant use with alcohol is also restricted due to this additive sedative effect and the increased risk of hepatotoxicity from Acetaminophen. Regular or high-dose use of the Acetaminophen component with Warfarin-type oral anticoagulants is documented to cause clinically significant elevations in INR, requiring close monitoring. Agents such as Propranolol may inhibit the metabolism of Acetaminophen, leading to increased pharmacological exposure.

Advertisements

Mechanism of Action

Relax, a centrally acting skeletal muscle relaxant (miorelaxant), primarily functions through the modulation of neurotransmission within the central nervous system, specifically targeting the brainstem and spinal cord. Its core mechanism involves interaction with alpha-2 adrenergic receptors as an agonist. Binding to these presynaptic receptors enhances inhibitory control over motor neurons. This engagement reduces the release of excitatory amino acids, such as glutamate and aspartate, from spinal interneurons. The decreased excitatory input at the motor neuron level leads to presynaptic inhibition, effectively reducing the facilitation of spinal motor neurons. Consequently, the downstream cascade results in a system-level decrease in skeletal muscle tone and hyperactivity. The modulation of these polysynaptic reflex pathways is the direct physiological consequence of the drug's receptor interaction.

Advertisements

Dosage and Administration Information

How to Use Relax (MIORELAXANT)

Relax (MIORELAXANT) is a fixed-dose combination product administered exclusively by the oral route as a tablet. The medication is officially indicated for use as an adjunct to rest, physical therapy, and other supportive measures during the management of acute musculoskeletal discomfort, not as a standalone, long-term primary treatment.


Standard Administration and Dosing

The regimen for the Chlorzoxazone component typically involves a starting dose of 250 mg to 500 mg per dose. This is administered three or four times daily to maintain relief during the acute symptomatic period. If the initial response is inadequate, the dose may be increased, potentially reaching 750 mg per dose. As the acute condition improves, the dosage is generally reduced.

The medication may be taken with or without food; however, a critical administration constraint is the total daily intake of the Acetaminophen component. Adults (aged 12 and older) must not exceed a total daily intake of 4,000 mg (4 grams) of Acetaminophen from all sources combined.


Use Constraints and Missed Doses

Use is structured for the short-term management of acute episodes. If a scheduled dose is missed, it should be taken as soon as possible, but if it is near the time for the next dose, the missed dose must be skipped. Doses should not be doubled. Furthermore, the safety and efficacy of the Chlorzoxazone component have not been established for official use in pediatric patients. Due to the Acetaminophen content, use is severely restricted or avoided in patients with severe hepatic impairment.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Relax (MIORELAXANT)

Research examining the fixed-dose combination product has been primarily derived from short-term Randomized Controlled Trials (RCTs). These studies were applied in research contexts involving fluctuating or unstable symptoms, such as sudden, acute low back pain or muscle sprains. The trials were designed to explore the medicine's profile when studied as an adjunct therapy for short-term symptoms.

Researchers mainly monitored two types of data. First, they focused on patient-reported outcomes describing perceived discomfort and changes in symptom intensity. Second, studies also explored outcomes reflecting daily functioning or activity level, which included clinical measures of muscle stiffness and overall movement ability. The collected data show patterns related to how symptoms evolved in the observed populations during the study period. This research provides context but not individual predictions.

Comparative Research and Placebo-Controlled Studies

The product was evaluated in settings comparing it to an inactive substance, known as a placebo. These comparison trials were applied in research exploring short-term symptom patterns. The combination product was evaluated in trials that included other active treatments, such as single-ingredient analgesics or other skeletal muscle relaxants, for comparison. Systematic reviews that synthesize this evidence contribute to the broader evidence landscape.

Duration of Study and Long-Term Follow-up Data

Research in this area is mainly characterized by follow-up durations that were limited, typically lasting only a few days up to two weeks. The studies were conducted during periods of increased symptom activity and explored short-term symptom changes. Consequently, outcomes for long-term use are not well characterized. There is limited information for long-term outcomes for use extending beyond the acute phase.

Research Gaps and Unanswered Questions

The existing research highlights what is known, but also what is still uncertain. Comparative evidence is lacking for certain head-to-head comparisons against non-relaxant medicines. Additionally, evidence quality varies across studies due to methodological differences, and this variability means the findings were mixed across the synthesized body of literature. These limitations explain why the evidence helps show what has been observed so far but does not determine whether an individual will respond similarly.

Key Studies & References DailyMed Label: Chlorzoxazone and Acetaminophen Tablet (Regulatory and Indication Scope)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Relax (MIORELAXANT) (FAQ)


Q: Is Relax (MIORELAXANT) in the same class of drugs as sedatives or anxiety medicines?

This medication is formally classified as a centrally acting skeletal muscle relaxant. It is also considered a Central Nervous System (CNS) depressant, which relates to its sedative properties. Official warnings state that combining it with other CNS depressants, such as sedatives or anxiety medicines, carries a risk of additive depression.


Q: Is it possible to develop an allergic reaction to the inactive ingredients in Relax (MIORELAXANT)?

The official label warns against use if a person has a known intolerance or hypersensitivity to the drug's components. Official labeling suggests reviewing the list of both active and inactive ingredients on the product label to check for potential allergies to any substance in the tablet.


Q: What should a patient generally expect the first time they take Relax (MIORELAXANT)?

Official information indicates that this medicine is used for the reduction of skeletal muscle spasm and associated relief of pain. Official sources note that some people may experience side effects such as nausea or vomiting, which can occur frequently at the initiation of treatment.


Q: What is the official guidance if a person feels no difference after taking Relax (MIORELAXANT)?

If the initial response to the medication is judged inadequate by a healthcare provider, official dosing recommendations state that the amount of the chlorzoxazone component may be increased. Such adjustments are made by a healthcare provider within approved dosage ranges.


Q: Is Relax (MIORELAXANT) generally described for pain not directly related to muscle injury or sprain?

Relax (MIORELAXANT) is formally indicated for discomfort associated with acute, painful musculoskeletal conditions, such as spasms and sprains. Since one of its active components is a non-opioid analgesic, the overall combination is described for conditions where both muscle spasm and pain are factors.


Q: Do you need a prescription from a doctor to get Relax (MIORELAXANT)?

Yes, this medication is classified by the U.S. regulatory system as a Human Prescription Drug. This means it is generally dispensed only with a valid prescription from a licensed healthcare provider.


Q: Is it normal to experience dry mouth or blurred vision when taking Relax (MIORELAXANT)?

Official labeling lists drowsiness and dizziness as the most common central nervous system effects. While dry mouth and blurred vision are not listed among the most frequently noted adverse effects on the official DailyMed label, these effects are sometimes reported with this class of centrally-acting muscle relaxants.


Q: Does Relax (MIORELAXANT) have any potential for physical dependence or addiction?

Because this medicine is a CNS depressant, regulatory documents emphasize its potential for misuse and dependence when used for long periods. This potential is a reason why the medication is typically prescribed and intended only for short-term use.


Q: Can Relax (MIORELAXANT) cause problems with insomnia or trouble sleeping for some users?

The common effect of this medication is drowsiness or sedation. While the official label does not list insomnia, regulatory information regarding the general drug class notes that prolonged or excessive use of muscle relaxants may potentially result in difficulty sleeping for some users.


Q: Does Relax (MIORELAXANT) affect the heart or heart rate?

The medication may have additive effects when taken with other drugs that affect the heart or blood pressure, such as certain beta-blockers. This combination can increase the potential for side effects like dizziness or fainting from low blood pressure.


Q: Can abruptly stopping Relax (MIORELAXANT) result in withdrawal symptoms?

The product label warns that abrupt withdrawal of certain CNS depressants can lead to adverse events. Official information suggests that abrupt discontinuation of extended therapy may not be advisable, and a discussion with a healthcare provider regarding gradual reduction may be needed.


Q: Is there a described interaction between Relax (MIORELAXANT) and common antidepressant medications?

The chlorzoxazone component is a Central Nervous System (CNS) depressant. Because of this, using it with certain types of antidepressant medications (like SSRIs) may increase shared side effects such as drowsiness, confusion, or difficulty concentrating.


Q: Are there any dietary restrictions or specific foods to avoid while taking Relax (MIORELAXANT)?

Official reports cited in regulatory sources indicate that consuming watercress may result in increased levels of the chlorzoxazone component in the body. This potential change in drug levels could lead to a greater risk of experiencing side effects.


Q: Can people with heart problems or conditions take Relax (MIORELAXANT)?

Official patient information resources generally state that the use of this medication in individuals with pre-existing heart impairment or heart conditions requires discussion with a healthcare provider.


Q: Does Relax (MIORELAXANT) interact with herbal supplements like St. John's Wort or Valerian root?

Official regulatory labeling advises exercising caution when taking the drug with various nutritional supplements and herbal products. Combining them carries a potential risk of interactions that may require careful monitoring or dose adjustments.


Q: How quickly does Relax (MIORELAXANT) typically start working after a person takes it?

According to the official regulatory documents on the drug's action, the onset of effect typically occurs relatively quickly. The muscle-relaxing effect can generally be expected to begin within 1 hour after taking an oral dose.


Q: How long can the muscle-relaxing effect of Relax (MIORELAXANT) be expected to last?

The expected duration of the primary muscle-relaxing effect is relatively short. Official information indicates that the clinical effect of the chlorzoxazone component typically lasts for approximately 3 to 4 hours.


Q: How long does Relax (MIORELAXANT) stay detectable in the body's system?

Pharmacokinetic data in the official label indicates that the half-life of the chlorzoxazone component is quite short, approximately 60 to 66 minutes. This data describes the rate at which the drug is processed, with less than 1% of the dose excreted unchanged in the urine within 24 hours.


Q: Is it better to take Relax (MIORELAXANT) at night due to its drowsy side effect?

Because this medicine has the potential to cause drowsiness and dizziness, official warnings advise patients to avoid activities that require high levels of mental alertness. Due to this safety consideration, administration at night may be suitable for certain patient circumstances.


Q: Does taking Relax (MIORELAXANT) regularly over time reduce its effectiveness?

Official information describes that tolerance can develop with the continued use of drugs that act as Central Nervous System (CNS) depressants. This is a pattern where the body adapts to the medication, and a user may require a higher amount to achieve the original intended effect.


Q: Is Relax (MIORELAXANT) used to treat conditions other than acute muscle spasms?

Official documentation explicitly states that the medicine is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions. This includes symptoms like muscle spasms, sprains, and strains that are related to sudden injury.


Q: Can Relax (MIORELAXANT) potentially interfere with or affect blood pressure readings?

Due to the medication's central nervous system effects, it may have additive effects when combined with certain medications that act to lower blood pressure. This could potentially result in symptoms of hypotension (abnormally low blood pressure).


Q: Is Relax (MIORELAXANT) described as having an abuse potential like some other central nervous system drugs?

Official patient information and regulatory labeling describe this drug class as having the potential for misuse and dependence or addiction. This is a major factor why the medicine is primarily intended and prescribed for short-term management.

Advertisements

How should Relax (MIORELAXANT) be stored and disposed of?

Official Storage and Disposal Requirements

Relax (MIORELAXANT) tablets must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The medication must be protected from light and moisture and kept from freezing and excessive heat to maintain stability. The container must be kept tightly closed and stored out of the sight and reach of children to prevent accidental ingestion.


For disposal, utilize an official drug take-back program whenever possible. If a program is unavailable, unused tablets should be mixed with an undesirable substance (e.g., used coffee grounds) and placed in a sealed container before discarding in the household trash. The medication is not recommended for disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Relax (MIORELAXANT) found in:

A-Z Index: